Joël Ménard

Active 1968–2020

Also published as
Joel Menard
77
Papers
18,419
Citations
70
h-index
76
i10-index

Citations

Citations per year for Joël Ménard1969: 3 citations1970: 2 citations1971: 1 citations1973: 1 citations1974: 2 citations1976: 10 citations1977: 2 citations1978: 4 citations1979: 4 citations1980: 5 citations1981: 8 citations1982: 6 citations1983: 11 citations1984: 16 citations1985: 11 citations1986: 22 citations1987: 28 citations1988: 25 citations1989: 29 citations1990: 25 citations1991: 35 citations1992: 22 citations1993: 39 citations1994: 31 citations1995: 37 citations1996: 42 citations1997: 68 citations1998: 80 citations1999: 92 citations2000: 127 citations2001: 138 citations2002: 101 citations2003: 139 citations2004: 137 citations2005: 122 citations2006: 112 citations2007: 111 citations2008: 85 citations2009: 90 citations2010: 81 citations2011: 87 citations2012: 114 citations2013: 96 citations2014: 88 citations2015: 100 citations2016: 100 citations2017: 106 citations2018: 93 citations2019: 272 citations2020: 270 citations2021: 232 citations2022: 211 citations2023: 169 citations2024: 249 citations2025: 124 citations2026: 3 citations1972: no citations, so this year is not shown1975: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,665 citing papers, 26.5% of this breakdownUnited Kingdom: 520 citing papers, 8.3% of this breakdownFrance: 355 citing papers, 5.6% of this breakdownItaly: 353 citing papers, 5.6% of this breakdownChina: 338 citing papers, 5.4% of this breakdownGermany: 309 citing papers, 4.9% of this breakdownAustralia: 261 citing papers, 4.1% of this breakdownCanada: 248 citing papers, 3.9% of this breakdownJapan: 187 citing papers, 3% of this breakdownNetherlands: 173 citing papers, 2.8% of this breakdownSwitzerland: 171 citing papers, 2.7% of this breakdownSweden: 159 citing papers, 2.5% of this breakdown
0%26.5%Other 24.7%

Fields

  • Medicine75.9%
  • Neuroscience10.6%
  • Biochemistry, Genetics and Molecular Biology6.4%
  • Health Professions1.5%
  • Nursing0.8%
  • Psychology0.6%
  • Other4.2%

Topics

  • Blood Pressure and Hypertension Studies7.8%
  • Hormonal Regulation and Hypertension5.8%
  • Renin-Angiotensin System Studies5.2%
  • Alzheimer's disease research and treatments3.2%
  • Cerebrospinal fluid and hydrocephalus2.8%
  • Sodium Intake and Health2.2%
  • Other73%

Coauthors

All papers

Open in search
  1. Clearance systems in the brain—implications for Alzheimer disease

    Authors: , , , , , , , , , , , , , , , - Nature Reviews Neurology 2015 cited by 1,668

  2. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

    Authors: , , , , , , , , , - The Lancet 1998 cited by 5,781

  3. Effects of a Novel Aldosterone Synthase Inhibitor for Treatment of Primary Hypertension

    Authors: , , , , , , , - Circulation 2011 cited by 213

  4. A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism

    Authors: , , , , , , , , , - Journal of Hypertension 2011 cited by 278

  5. Aldosterone Synthase Inhibition With LCI699

    Authors: , , , , , - Hypertension 2010 cited by 195

  6. Serial left ventricular adaptations in world-class professional cyclists

    Authors: , , , , , , - Journal of the American College of Cardiology 2004 cited by 253

  7. Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension

    Authors: , , , , - Hypertension 2020 cited by 90

  8. Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension

    Authors: , , , , , , , , , , , , , - Journal of Pharmacology and Experimental Therapeutics 2019 cited by 58

  9. Aldosterone synthase inhibition in humans

    Authors: , , - Nephrology Dialysis Transplantation 2012 cited by 98

  10. Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate Measurement

    Authors: , , , , , , - Clinical Chemistry 2009 cited by 187

  11. Unemployment is associated with high cardiovascular event rate and increased all-cause mortality in middle-aged socially privileged individuals

    Authors: , , , , , , - International Archives of Occupational and Environmental Health 2014 cited by 96

  12. Trends in Worldwide Research in Hypertension Over the Period 1999–2018

    Authors: , - Hypertension 2020 cited by 65

  13. Efficacy and tolerance of spironolactone in essential hypertension

    Authors: , , , , , , , - The American Journal of Cardiology 1987 cited by 271

  14. Reproducibility of the 6-minute Walk Test in Obese Adults

    Authors: , , , , , , - International Journal of Sports Medicine 2009 cited by 162

  15. Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects

    Authors: , , , , , - Journal of the American College of Cardiology 2011 cited by 123

  16. Bibliometric analysis of research relating to hypertension reported over the period 1997–2016

    Authors: , - Journal of Hypertension 2019 cited by 94

  17. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.

    Authors: , , , , , , , , - Journal of Clinical Investigation 1996 cited by 339

  18. Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study)

    Authors: , , , , , - BMJ 2004 cited by 292

  19. Masked hypertension: a systematic review

    Authors: , , , , , - Journal of Hypertension 2008 cited by 265

  20. The 45-year story of the development of an anti-aldosterone more specific than spironolactone

    Authors: - Molecular and Cellular Endocrinology 2003 cited by 103

  21. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.

    Authors: , , , , , - BMJ 1988 cited by 384

  22. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria.

    Authors: , , , , , - BMJ 1987 cited by 262

  23. Antiandrogenic Effect of Spirolactones: Mechanism of Action

    Authors: , , , , - Endocrinology 1975 cited by 258

  24. The number needed to treat: a clinically useful nomogram in its proper context

    Authors: , , , , - BMJ 1996 cited by 204